Structures by: Solntsev P. V.
Total: 89
Copper(I) Tetrafluoroborate 4:5 complex with 1,4-bi(pyridazin-4-yl)benzene, solvate with 4 Chloroform
C74H54B4Cl12Cu4F16N20
New Journal of Chemistry (2008) 32, 11 1910
a=12.5703(9)Å b=13.7895(13)Å c=14.1629(12)Å
α=94.203(11)° β=93.205(11)° γ=107.835(10)°
Copper(I) Dithionate bis(Acetonitrile) complex with 1,4-bi(pyridazin-4-yl)benzene
C18H16Cu2N6O6S2
New Journal of Chemistry (2008) 32, 11 1910
a=9.3471(6)Å b=18.9283(11)Å c=12.4791(9)Å
α=90.00° β=101.718(8)° γ=90.00°
Silver(I) nitrate 1:1 complex with 1,4-bi(pyridazin-4-yl)benzene, Chloroform solvate
C15H11AgCl3N5O3
New Journal of Chemistry (2008) 32, 11 1910
a=8.3964(2)Å b=9.5399(2)Å c=12.4383(3)Å
α=80.0473(10)° β=82.901(2)° γ=64.9520(11)°
Silver(I) Pentafluoropropionate 1:1 complex with 1,4-bi(pyridazin-4-yl)benzene
C17H10AgF5N4O2
New Journal of Chemistry (2008) 32, 11 1910
a=5.5566(7)Å b=10.5875(13)Å c=15.419(2)Å
α=72.987(10)° β=84.721(11)° γ=82.058(11)°
Silver(I) Trifluoroacetate 4:3 complex with 1,4-bi(pyridazin-4-yl)benzene, Acetonitrile solvate
C52H33Ag4F12N13O8
New Journal of Chemistry (2008) 32, 11 1910
a=10.9059(10)Å b=11.1531(11)Å c=13.8012(13)Å
α=92.620(11)° β=108.916(11)° γ=117.522(10)°
Silver(I) Methanesulfonate 4:3 complex with 1,4-bi(pyridazin-4-yl)benzene, solvate with 2 Chloroform
C48H44Ag4Cl6N12O12S4
New Journal of Chemistry (2008) 32, 11 1910
a=19.3101(19)Å b=17.3714(15)Å c=18.1903(15)Å
α=90.00° β=99.346(5)° γ=90.00°
Silver(I) Benzoate 2:1 complex with 1,4-bi(pyridazin-4-yl)benzene, Hydrate
C28H24Ag2N4O6
New Journal of Chemistry (2008) 32, 11 1910
a=7.2863(3)Å b=14.3867(6)Å c=12.2774(5)Å
α=90.00° β=90.945(3)° γ=90.00°
C64H46Fe2N4Sn1
C64H46Fe2N4Sn1
Chemical communications (Cambridge, England) (2010) 46, 35 6581-6583
a=10.7368(10)Å b=11.2881(10)Å c=12.1733(11)Å
α=101.6570(10)° β=108.0820(10)° γ=115.0580(10)°
Silver(i) Perchlorate 4:5 Complex with Pyridazino(4,5- d)pyridazine
(C30H20Ag4N20),4(ClO4)
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=17.0076(10)Å b=17.0076(10)Å c=7.8591(5)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Trifluorometanesulfonate Complex with Pyridazino(4,5-d)pyridazine, Solvate with 0.33 Water
C18H14Ag3N12O,3(CF3O3S)
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=15.6887(9)Å b=15.6887(9)Å c=24.4805(18)Å
α=90.00° β=90.00° γ=120.00°
Silver(i) Hexaflurosilicate Tetrafluoroborate Complex with Pyridazino(4,5-d)pyridazine Hydrate
2(C15H10Ag2N10),F6Si,2(BF4),4(H2O)
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=17.0801(11)Å b=17.0782(11)Å c=7.5920(7)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Nitrate complex with 1,2,4,5-tetrazine
(C2H2N4),Ag,(NO3)
Dalton Transactions (2009) 15 2856-2864
a=7.7351(7)Å b=10.8172(8)Å c=7.1540(6)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Perchlorate complex with 1,2,4,5-tetrazine
(C2H2N4),Ag,(ClO4)
Dalton Transactions (2009) 15 2856-2864
a=8.4650(7)Å b=10.4250(11)Å c=7.7750(6)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Nitrate 2:1 complex with 3,6-dimethyl-1,2,4,5- tetrazine
(C4H6N4),2Ag,2(NO3)
Dalton Transactions (2009) 15 2856-2864
a=9.0359(8)Å b=13.2071(13)Å c=8.7513(7)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Perchlorate 2:1 complex with 3,6-dimethyl-1,2,4,5- tetrazine, Dihydrate
(C4H6N4),2Ag,2(ClO4),2(H2O)
Dalton Transactions (2009) 15 2856-2864
a=6.7481(8)Å b=7.9981(9)Å c=8.1382(10)Å
α=65.302(11)° β=65.663(10)° γ=66.151(11)°
Copper(i) chloride 4:1 complex with 3,6-dimethyl-1,2,4,5- tetrazine
C4H6N4,4(CuCl)
Dalton Transactions (2009) 15 2856-2864
a=6.8143(9)Å b=6.2582(8)Å c=13.6220(17)Å
α=90.00° β=98.907(4)° γ=90.00°
Silver(i) Triflate 3:1 complex with 2,6-dimethyl-1,2,4,5- tetrazine, dihydrate
2(C4H6N4),6Ag,6(CF3O3S),4(H2O)
Dalton Transactions (2009) 15 2856-2864
a=10.5847(9)Å b=19.0579(13)Å c=23.1327(14)Å
α=90.00° β=102.038(10)° γ=90.00°
Copper(ii) acetate 2:1 complex with 4,4'-Bipyridazine, Dihydrate
C8H9CuN2O4,2(H2O)
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=7.4144(9)Å b=8.2275(9)Å c=10.9023(13)Å
α=76.965(14)° β=82.505(13)° γ=63.267(13)°
Zinc(ii) Nitrate 1:1 Complex with 4,4'-Bipyridazine
C8H6N6O6Zn
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=6.07500(10)Å b=16.9431(3)Å c=11.9592(2)Å
α=90.00° β=101.3800(10)° γ=90.00°
Copper(ii) Dithionate 1:2 Complex with 4,4'-Bipyridazine, Dihydrate
C16H16CuN8O2,O6S2
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=15.1065(13)Å b=11.8885(9)Å c=11.0631(10)Å
α=90.00° β=90.00° γ=90.00°
Copper(ii) Trifluoroacetate 2:3 Complex with 4,4'-Bipyridazine
C32H18CU2F12N12O8
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=10.4940(6)Å b=10.9798(8)Å c=18.3058(13)Å
α=90.00° β=98.572(5)° γ=90.00°
Copper(ii) Tetrafluoroborate 1:2 Complex with 4,4'- Bipyridazine, Solvate with 3.33 Water
C48H36Cu3N24O4,6(BF4),6(H2O)
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=12.0861(8)Å b=14.6555(8)Å c=21.5673(15)Å
α=90.00° β=104.025(8)° γ=90.00°
Dihydroxotricopper(ii) Trifluoroacetate Complex with 4,4'- Bipyridazine, Tetrahydrate
(C28H24Cu3F6N12O8),2(C2F3O2),2(H2O)
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=15.4234(9)Å b=15.7761(12)Å c=19.1034(12)Å
α=90.00° β=108.591(6)° γ=90.00°
Copper(i) Chloride 2:1 Complex with 4,4'-Bipyridazine
C8H6CL2CU2N4
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=6.617(2)Å b=13.132(4)Å c=6.642(2)Å
α=90.00° β=114.23(2)° γ=90.00°
Copper(i) Bromide 2:1 Complex with 4,4'-Bipyridazine
C8H6Br2Cu2N4
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=6.712(2)Å b=13.450(4)Å c=6.807(3)Å
α=90.00° β=112.79(3)° γ=90.00°
Copper(i) Iodide 2:1 Complex with 4,4'-Bipyridazine
C8H6Cu2I2N4
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=10.1405(5)Å b=10.1405(5)Å c=11.9784(7)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Hexafluorosilicate 2:3 Complex with Pyridazino(4,5- d)pyridazine, Decahydrate
C18H20Ag4N12O4,2(F6Si),6(H2O)
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=8.85070(10)Å b=17.2093(3)Å c=12.0859(2)Å
α=90.00° β=100.7850(10)° γ=90.00°
Silver(i) Trifluoroacetate Complex with Pyridazino(4,5- d)pyridazine
C8H4AgF3N4O2
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=7.3514(2)Å b=12.5897(3)Å c=11.3054(3)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Pentafluoropropionate 2:1 Complex with Pyridazino(4,5-d)pyridazine
C12H4Ag2F10N4O4
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=25.2810(10)Å b=25.2810(10)Å c=7.4007(4)Å
α=90.00° β=90.00° γ=120.00°
Silver(i) Hexafluorosilicate 2:3 Complex with 4,4'- Bipyridazine, Trihydrate
C24H22Ag4N12O2,2(F6Si),H2O
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=7.7384(2)Å b=38.1690(8)Å c=50.8067(10)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Tetrafluoroborate 4:3 Complex with 4,4'- Bipyridazine Hydrate
(C24H18Ag4N12),4(BF4),(H2O)
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=10.6823(8)Å b=12.1323(7)Å c=14.6844(9)Å
α=90.00° β=97.017(8)° γ=90.00°
Silver(i) Trifluoromethylsulfonate Complex with 4,4'- Bipyridazine, Solvate with 2/3 Water
C24H20Ag3N12O,3(CF3O3S),H2O
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=8.7652(6)Å b=22.1004(15)Å c=10.4417(7)Å
α=90.00° β=91.8740(10)° γ=90.00°
Silver(i) Heptafluorobutyrate 2:1 Complex with 4,4'- Bipyridazine
C16H6Ag2F14N4O4
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=28.4273(11)Å b=28.4273(11)Å c=7.5353(3)Å
α=90.00° β=90.00° γ=120.00°
Silver(i) Pentafluoropropionate 2:1 Complex with 4,4'- Bipyridazine
C14H6Ag2F10N4O4
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=26.9862(12)Å b=26.9862(12)Å c=7.6176(4)Å
α=90.00° β=90.00° γ=120.00°
Silver(i) Trifluoroacetate 2:1 Complex with 4,4'- Bipyridazine, Solvate with 2/7 Chloroform
C84H42Ag14F42N28O28,2(CHCl3)
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=13.9023(2)Å b=14.4405(3)Å c=18.2666(2)Å
α=107.0790(10)° β=111.5920(10)° γ=94.2320(10)°
Silver(I) Isophthalate 1:1 complex with 1,4-bi(pyridazin-4-yl)benzene, Hydrate
C66H62Ag6N12O22
New Journal of Chemistry (2008) 32, 11 1910
a=9.4238(6)Å b=14.2038(12)Å c=14.2032(10)Å
α=104.457(8)° β=98.140(8)° γ=108.924(9)°
Copper(i) Bromide 2:1 Complex with 1,2,3,6,7,8-Hexahydro- cinnolino(5,4,3-cde)cinnoline, dichloromethane solvate
C13H14Br2Cl2Cu2N4
Dalton transactions (Cambridge, England : 2003) (2004) 8 1153-1158
a=17.7304(19)Å b=17.7304(19)Å c=12.6008(11)Å
α=90.00° β=90.00° γ=90.00°
Copper(i) Iodide 2:1 Complex with 1,2,3,6,7,8-Hexahydro- cinnolino(5,4,3-cde)cinnoline
C12H12Cu2I2N4
Dalton transactions (Cambridge, England : 2003) (2004) 8 1153-1158
a=12.3475(10)Å b=12.3475(10)Å c=13.2122(12)Å
α=90.00° β=90.00° γ=90.00°
Copper(i) Bromide 2:1 Complex with 1,2,3,6,7,8-Hexahydro- cinnolino(5,4,3-cde)cinnoline
C12H12Br2Cu2N4
Dalton transactions (Cambridge, England : 2003) (2004) 8 1153-1158
a=12.3176(11)Å b=12.3176(11)Å c=12.772(2)Å
α=90.00° β=90.00° γ=90.00°
Copper(i) Iodide 2:1 Complex with 1,2,3,6,7,8-Hexahydro- cinnolino(5,4,3-cde)cinnoline, chloroform solvate
C13H13Cl3Cu2I2N4
Dalton transactions (Cambridge, England : 2003) (2004) 8 1153-1158
a=17.614(2)Å b=17.614(2)Å c=13.136(2)Å
α=90.00° β=90.00° γ=90.00°
Copper(i) Iodide 3:1 Complex with 1,2,3,6,7,8-Hexahydro- cinnolino(5,4,3-cde)cinnoline, acetonitrile solvate
C80H84Cu18I18N28
Dalton transactions (Cambridge, England : 2003) (2004) 8 1153-1158
a=20.463(2)Å b=20.463(2)Å c=17.989(2)Å
α=90.00° β=90.00° γ=120.00°
Copper(i) Iodide 2:1 Complex with 2,2,7,7-Tetramethyl- 1,2,3,6,7,8-Hexahydro-cinnolino(5,4,3-cde)cinnoline, dichloromethane solvate
C17H22Cl2Cu2I2N4
Dalton transactions (Cambridge, England : 2003) (2004) 8 1153-1158
a=26.1899(14)Å b=26.1899(14)Å c=9.6096(10)Å
α=90.00° β=90.00° γ=120.00°
Copper(i) Iodide 2:1 Complex with 2,2,7,7-Tetramethyl- 1,2,3,6,7,8-Hexahydro-cinnolino(5,4,3-cde)cinnoline, acetonitrile solvate
C18H23Cu2I2N5
Dalton transactions (Cambridge, England : 2003) (2004) 8 1153-1158
a=24.063(3)Å b=13.5575(16)Å c=6.8122(8)Å
α=90.00° β=90.00° γ=90.00°
Copper(i) Bromide 4:1 Complex with 1,2,3,6,7,8-Hexahydro- cinnolino(5,4,3-cde)cinnoline, acetonitrile solvate
C16H18Cu4I4N6
Dalton transactions (Cambridge, England : 2003) (2004) 8 1153-1158
a=7.6797(9)Å b=7.7125(9)Å c=11.3151(10)Å
α=104.415(2)° β=104.170(2)° γ=96.141(2)°
Copper(ii) Perchlorate 1:2 Complex with 2,2,7,7-tetramethyl- 1,2,3,6,7,8-hexahydro-cinnolino(5,4,3-cde)cinnoline
C32H40Cl2CuN8O8
Dalton transactions (Cambridge, England : 2003) (2004) 5 695-696
a=12.2179(11)Å b=12.2179(11)Å c=11.7783(14)Å
α=90.00° β=90.00° γ=90.00°
Copper(ii) Nitrate 1:2 Complex with 1,2,3,6,7,8-hexahydro- cinnolino(5,4,3-cde)cinnoline, Chloroform solvate
C27H27Cl9CuN10O6
Dalton transactions (Cambridge, England : 2003) (2004) 5 695-696
a=23.5623(10)Å b=23.5623(10)Å c=23.5623(10)Å
α=90.00° β=90.00° γ=90.00°
Copper(ii) Perchlorate 1:2 Complex with 1,2,3,6,7,8-hexahydro- cinnolino(5,4,3-cde)cinnoline, Chloroform solvate
C27H27Cl11CuN8O8
Dalton transactions (Cambridge, England : 2003) (2004) 5 695-696
a=23.7035(14)Å b=23.7035(14)Å c=23.7035(14)Å
α=90.00° β=90.00° γ=90.00°
1,2,6,6a,7,8,14,14a-octahydrobenzo[f]naphtho[2,1-c]cinnoline- 9,12(5H,13H)-dihydrazone, Solvate with Ethanol and Water
2(C20H24N6),C2H6O,H2O
Chem.Commun. (2012) 48, 5847
a=10.7110(10)Å b=11.5603(11)Å c=18.6159(16)Å
α=76.538(6)° β=90.023(6)° γ=62.401(7)°
1,2,6,6a,7,7a,8,9,17,17a,18,18a-dodecahydroanthra[2,1-c]naphtho- [2,3-f]cinnoline-10,15(5H,16H)-dihydrazone, Ethanol solvate
C28H32N6,C2H6O
Chem.Commun. (2012) 48, 5847
a=17.8207(6)Å b=6.1397(2)Å c=24.7531(8)Å
α=90.00° β=100.4510(10)° γ=90.00°
3,4,4a,5,6,9,10,10a,11,12-decahydroanthra [1,9,8-cdef:5,10,4-cdef]dicinnoline, Dihydrate
C20H18N4,2(H2O)
Chem.Commun. (2012) 48, 5847
a=5.0227(5)Å b=13.5312(14)Å c=12.4146(15)Å
α=90.00° β=94.498(8)° γ=90.00°
(3,4,4a,5,6,9,10,10a,11,12-decahydroanthra [1,9,8-cdef:5,10,4-cdef]dicinnoline)diiododicopper(I), Solvate with Acetonitrile and Chloroform
(C20H18Cu2I2N4),CHCl3,C2H3N
Chem.Commun. (2012) 48, 5847
a=22.3792(2)Å b=22.3792(2)Å c=13.1261(3)Å
α=90.00° β=90.00° γ=90.00°
(3,4,4a,5,6,9,10,10a,11,12-decahydroanthra [1,9,8-cdef:5,10,4-cdef]dicinnoline)dichlorodicopper(I), Solvate with 4 Acetonitrile
C20H18Cl2Cu2N4,4(C2H3N)
Chem.Commun. (2012) 48, 5847
a=15.9327(9)Å b=15.9327(9)Å c=12.4522(10)Å
α=90.00° β=90.00° γ=90.00°
Zinc Nitrate 1:1 Complex with Pyridazino(4,5-d)pyridazine
C6H12N4O4Zn,2(NO3)
Chemical Communications (2006) 46
a=6.3661(7)Å b=7.5923(9)Å c=8.0357(9)Å
α=103.580(10)° β=103.119(10)° γ=109.693(10)°
Copper(ii) Nitrate 1:2 Complex with Pyridazino(4,5- d)pyridazine, Tetrahydrate
C12H12CuN8O2,2(NO3),2(H2O)
Chemical Communications (2006) 46
a=13.1173(9)Å b=13.2215(9)Å c=12.0518(8)Å
α=90.00° β=113.404(2)° γ=90.00°
Hydroxocopper(ii) Sulfamate Complex with Pyridazino(4,5- d)pyridazine, Monohydrate
C6H5CuN4O,H2NO3S,H2O
Chemical Communications (2006) 46
a=6.7875(7)Å b=10.5615(9)Å c=14.2118(11)Å
α=90.00° β=97.567(10)° γ=90.00°
Silver(I) Methanesulfonate Complex with Pyridazino[4,5-d]pyridazine, Dihydrate
C6H6AgN4O,CH3O3S,H2O
Chemical Communications (2006) 46
a=7.4389(5)Å b=10.5720(10)Å c=14.7775(10)Å
α=90.00° β=90.00° γ=90.00°
Poly[[aqua-μ~4~-pyridazino[4,5-d]pyridazine-μ~3~-sulfato-disilver(I)] monohydrate]
C6H6Ag2N4O5S,H2O
Acta Crystallographica Section C (2007) 63, 6 m259-m263
a=8.3733(2)Å b=8.7790(2)Å c=8.9006(3)Å
α=85.9270(10)° β=74.334(2)° γ=68.8160(10)°
Poly[[μ~4~-4,4-bipyridazine-μ~5~-sulfato-disilver(I)] monohydrate]
C8H6Ag2N4O4S,H2O
Acta Crystallographica Section C (2007) 63, 6 m259-m263
a=7.4829(9)Å b=8.4881(10)Å c=10.9267(10)Å
α=67.172(9)° β=88.971(8)° γ=67.092(8)°
4,4'-(<i>p</i>-phenylene)bipyridazine
C14H10N4
Acta Crystallographica Section C (2008) 64, 7 m254-m258
a=6.3588(7)Å b=6.9307(9)Å c=7.0681(10)Å
α=110.282(3)° β=90.823(3)° γ=106.585(2)°
Catena-poly[[dibromidocopper(II)]-μ~2~-4,4-(<i>p</i>-phenylene)bipyridazine- κ^2^N^2^:N^2'^]
C14H10Br2CuN4
Acta Crystallographica Section C (2008) 64, 7 m254-m258
a=4.1377(2)Å b=12.5407(7)Å c=13.5301(8)Å
α=90.00° β=93.786(4)° γ=90.00°
Catena-poly[[[tetrakis(μ-acetato-κ^2^<i>O</i>:<i>O</i>)dicopper(II)]- μ~2~-4,4'-(<i>p</i>-phenylene)bipyridazine-κ^2^N^1^:N^1'^] chloroform disolvate]
C22H22Cu2N4O8,2(CHCl3)
Acta Crystallographica Section C (2008) 64, 7 m254-m258
a=7.6349(8)Å b=8.0203(8)Å c=13.9312(10)Å
α=104.601(2)° β=103.993(2)° γ=90.123(3)°
Poly[di-μ-chlorido-μ-(4,4-bipyridazine)-κ^2^<i>N</i>^1^:<i>N</i>^1'^- cadmium(II)]
C8H6CdCl2N4
Acta Crystallographica Section C (2012) 68, 11 m295-m299
a=11.7374(10)Å b=11.6511(10)Å c=7.5484(8)Å
α=90.00° β=90.00° γ=90.00°
Poly[di-μ-bromido-μ-(4,4-bipyridazine)-κ^2^<i>N</i>^1^:<i>N</i>^1'^- cadmium(II)]
C8H6Br2CdN4
Acta Crystallographica Section C (2012) 68, 11 m295-m299
a=11.7549(8)Å b=11.9619(8)Å c=7.8690(6)Å
α=90.00° β=90.00° γ=90.00°
Poly[[tetra-μ-iodido-μ~4~-(4,4-bipyridazine)- κ^4^<i>N</i>^1^:<i>N</i>^2^:<i>N</i>^1'^:<i>N</i>^2'^-dicadmium(II)]
C8H6Cd2I4N4
Acta Crystallographica Section C (2012) 68, 11 m295-m299
a=8.0106(6)Å b=14.3621(13)Å c=7.6850(6)Å
α=90.00° β=115.855(8)° γ=90.00°
Catena-Poly[[aqua(dinitrato-κ^2^O,O)cadmium(II)]-μ-1,2,3,6,7,8- hexahydrocinnolino[5,4,3-cde]cinnoline-κN^1^:κN^6^]
C12H14CdN6O7
Acta Crystallographica Section C (2006) 62, 2 m70-m73
a=7.3240(6)Å b=13.7493(12)Å c=15.9016(13)Å
α=90.00° β=90.720(2)° γ=90.00°
Catena-poly[[[(dinitrato-κ^2^O,O)cadmium(II)]-μ-2,2,7,7-tetramethyl- 1,2,3,6,7,8-hexahydrocinnolino[5,4,3-cde]cinnoline-κN^1^:κN^6^] chloroform solvate]
C16H20CdN6O6,CHCl3
Acta Crystallographica Section C (2006) 62, 2 m70-m73
a=12.2570(12)Å b=12.5085(11)Å c=15.8471(14)Å
α=90.00° β=102.687(2)° γ=90.00°
1,4,5,8-Tetramethylpyridazino[4,5-<i>d</i>]pyridazine trihydrate
C10H12N4,3(H2O)
Acta Crystallographica Section C (2008) 64, 4 o237-o241
a=9.8804(8)Å b=6.6540(7)Å c=18.3908(12)Å
α=90.00° β=90.00° γ=90.00°
1,2,3,6,7,8-Hexahydrocinnolino[5,4,3-cde]cinnoline tetrahydrate
C12H12N4,4(H2O)
Acta Crystallographica Section C (2008) 64, 4 o237-o241
a=6.6745(14)Å b=20.028(4)Å c=5.4860(11)Å
α=90.00° β=106.352(3)° γ=90.00°
C26H24Fe2O4
C26H24Fe2O4
Organometallics (2011) 30, 11 3037
a=8.9925(18)Å b=11.639(2)Å c=11.748(2)Å
α=93.01(3)° β=102.02(3)° γ=112.70(3)°
C24H19Fe2NO2,CH2Cl2
C24H19Fe2NO2,CH2Cl2
Organometallics (2011) 30, 11 3037
a=10.253(2)Å b=11.074(2)Å c=11.120(2)Å
α=63.18(3)° β=80.01(3)° γ=87.34(3)°
Bis(dimethyl-(Z)-2-ferrocenyl-1-butenedioate)mercury
C32H30Fe2HgO8
Organometallics (2011) 30, 24 6636
a=8.902(5)Å b=12.776(5)Å c=13.799(5)Å
α=90.00° β=110.321(5)° γ=90.00°
Diferrocene
C20H18Fe2
Organometallics (2011) 30, 24 6636
a=9.5320(5)Å b=7.7830(3)Å c=12.4190(11)Å
α=90.00° β=126.384(5)° γ=90.00°
[NMe_4]_2 [L_2 Cu_4 (μ_4-O)]
C52H28Cu4N12O9
Journal of the American Chemical Society (2014) 136, 20 7269-7272
a=14.5216(7)Å b=14.5216(7)Å c=15.9314(11)Å
α=90° β=90° γ=90°
[NMe_4] [L_2 Cu_2 (μ-OH)]
C32.76H27Cu2N8.38O6.62
Journal of the American Chemical Society (2014) 136, 20 7269-7272
a=8.9723(2)Å b=16.1009(4)Å c=11.4418(3)Å
α=90° β=105.978(2)° γ=90°
[NMe_4]_2 [L_2 Cu_4 (μ_4-O)]
C52H28Cu4N12O9,2(C3H7NO),2(C4H12N),4(H2O)
Journal of the American Chemical Society (2014) 136, 20 7269-7272
a=16.690(2)Å b=17.558(2)Å c=24.517(3)Å
α=90° β=90° γ=90°
C70H53Fe5InN4,4(C60)
C70H53Fe5InN4,4(C60)
Inorganic Chemistry (2013) 52, 9496-9510
a=36.8912(7)Å b=36.8912(7)Å c=24.7083(17)Å
α=90° β=90° γ=90°
C70H53Fe5InN4
C70H53Fe5InN4
Inorganic Chemistry (2013) 52, 9496-9510
a=13.7094(6)Å b=14.5527(9)Å c=15.8180(11)Å
α=69.953(5)° β=76.118(5)° γ=63.423(5)°
C60H44ClFe4InN4,0.84(C7H8)
C60H44ClFe4InN4,0.84(C7H8)
Inorganic Chemistry (2013) 52, 9496-9510
a=11.2415(3)Å b=15.3866(3)Å c=16.2741(11)Å
α=82.613(6)° β=81.185(6)° γ=76.854(5)°
Copper(ii) Perchlorate 1:2 Complex with Pyridazino(4,5- d)pyridazine, Hexahydrate
C12H12CuN8O2,2(ClO4),4(H2O)
Chemical Communications (2006) 46
a=7.3893(8)Å b=9.0008(9)Å c=9.0474(9)Å
α=92.650(10)° β=107.178(10)° γ=95.598(10)°
C35H21BFeN6O2
C35H21BFeN6O2
Inorganic Chemistry (2012) 51, 6537-6547
a=17.2645(8)Å b=7.7863(2)Å c=20.6276(14)Å
α=90.00° β=95.019(7)° γ=90.00°
C24H12BClN6
C24H12BClN6
Inorganic Chemistry (2012) 51, 6537-6547
a=12.1224(2)Å b=14.8449(10)Å c=10.32830(10)Å
α=90.00° β=90.00° γ=90.00°
C35H23BFeN6O
C35H23BFeN6O
Inorganic Chemistry (2012) 51, 6537-6547
a=28.610(5)Å b=11.197(5)Å c=18.146(5)Å
α=90.00° β=114.658(5)° γ=90.00°
3,4-diiodo-1-tris(isopropyl)silylpyrrol
C13H23I2NSi
Organometallics (2014) 33, 1 145
a=9.6249(6)Å b=21.7670(5)Å c=8.7272(2)Å
α=90.00° β=107.464(8)° γ=90.00°
3,4-diferrocenyl-1-tris(isopropyl)silylpyrrol
C33H41Fe2NSi
Organometallics (2014) 33, 1 145
a=7.3670(3)Å b=12.3067(5)Å c=17.1322(12)Å
α=110.563(8)° β=98.491(7)° γ=94.446(7)°
5-hydroxy-3,4-diferrocenyl-2,5-dihydro-1H-pyrrol-2-one
C24H21Fe2NO2,(C7H8)
Organometallics (2014) 33, 1 145
a=10.6624(10)Å b=16.3329(17)Å c=16.944(2)Å
α=108.949(8)° β=106.427(8)° γ=104.233(7)°
C28H18BF2N3
C28H18BF2N3
Inorganic chemistry (2015) 54, 8 4167-4174
a=10.1748(7)Å b=8.4521(5)Å c=23.5825(16)Å
α=90° β=91.453(6)° γ=90°
C28H19N3
C28H19N3
Inorganic chemistry (2015) 54, 8 4167-4174
a=33.0628(7)Å b=33.0628(7)Å c=4.8770(3)Å
α=90° β=90° γ=120°
C34H21BFeN6
C34H21BFeN6
Inorganic chemistry (2014) 53, 17 9336-9347
a=10.0410(4)Å b=11.8991(5)Å c=12.3514(8)Å
α=102.901(7)° β=105.917(8)° γ=107.811(8)°
4(C36H21N6Fe1B1),CH2Cl2
4(C36H21N6Fe1B1),CH2Cl2
Inorganic chemistry (2014) 53, 17 9336-9347
a=13.2281(8)Å b=13.6458(9)Å c=19.1772(14)Å
α=71.365(5)° β=89.078(6)° γ=71.701(5)°